Clenbuterol (CST-103)

clenbuterol · CuraSen Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Clenbuterol (CST-103), covering 2024-12-02 to 2024-12-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders [Phase 2]

See pricing